Skip to main content
Premium Trial:

Request an Annual Quote

Genzyme Joins International Initiative to Help Develop Malaria Drugs

NEW YORK (GenomeWeb News) — Genzyme will join an international public/private initiative to develop malaria drugs, the company said yesterday.
 
The company will work with the Medicines for Malaria Venture, MIT’s Broad Institute, and Harvard University to develop treatments by identifying compounds that the company claims offer a new approach to treating the disease.
 
Genzyme said there are four discovery projects ongoing already, but did not disclose their specifics. The company added that any intellectual property stemming from the research will be made available to the MMV for drug development without royalties.  
 
MMV, a non-profit organization aimed at finding new antimalarial treatments, estimates that there are 300 million to 600 million new clinical cases of malaria each year.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.